Literature DB >> 8154027

Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life.

D K Hathaway1, T Abell, S Cardoso, M S Hartwig, S el Gebely, A O Gaber.   

Abstract

We conducted a series of studies to document changes in autonomic and gastrointestinal function following pancreas-kidney and kidney-alone transplantation, define how autonomic function is associated with quality of life, and identify how transplantation alters the quality of life of diabetic transplant recipients. Uremic type I diabetic patients receiving combined pancreas-kidney (n = 23) or kidney-alone (n = 16) transplants completed pre- and 12-month-posttransplant evaluation of vasomotor function (total capillary pulse amplitude, capillary vasoconstriction response to cold, capillary response to postural adjustments), cardiac function (R-R interval variation, valsalva ratio), overall autonomic function (total autonomic score, autonomic index), gastric function (cutaneous electrogastrography, gastric emptying, total gastrointestinal symptoms score), and quality of life (sickness impact profile). Kidney recipients experienced nonsignificant improvement in autonomic function with significant improvement in total symptom score. In contrast, pancreas-kidney recipients demonstrated significant improvement in postural adjustment ratio (P < or = .0085), valsalva ratio (P < or = .0348), electrogastography (P < or = .0159), and total symptom score (P < or = .0001). Improvement or stabilization of gastric function occurred for 12 of 23 pancreas-kidney patients (52%) versus 5 of 12 kidney-alone patients (41.7%). A path analysis of 56 diabetic patients having a wide range in diabetic autonomic neuropathy, found the sickness impact profile to correlate with valsalva ratio (r = .36, P < or = .0056), R-R interval (r = .27, P < or = .0396), and vasoconstriction (r = .24, P < or = .064). Together, autonomic function measures accounted for 15.2% of the total variance in the sickness impact profile. Sickness impact profile scores also significantly improved for both groups of transplant recipients.

Entities:  

Mesh:

Year:  1994        PMID: 8154027     DOI: 10.1097/00007890-199403270-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

Review 1.  Islet versus pancreas transplantation in type 1 diabetes: competitive or complementary?

Authors:  Barbara Ludwig; Stefan Ludwig; Anja Steffen; Hans-Detlev Saeger; Stefan R Bornstein
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

Review 2.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

3.  Transient impact of hemodialysis on gastric myoelectrical activity of uremic patients.

Authors:  C W Ko; C S Chang; M J Wu; G H Chen
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

Review 4.  Pancreas transplantation.

Authors:  R J Stratta; R J Taylor; J L Larsen; K Cushing
Journal:  Int J Pancreatol       Date:  1995-02

Review 5.  Pancreatic and islet transplantation.

Authors:  L Rosenberg
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 6.  Pancreas and kidney transplantation.

Authors:  Jennifer Larsen; James Lane; Lynn Mack-Shipman
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 7.  Gastrointestinal disturbances in diabetes.

Authors:  Manju Chandran; Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 8.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

Review 9.  [Pancreas and islet transplantation. The role in the treatment of diabetes mellitus].

Authors:  P Schenker; R Viebahn
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

10.  Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes.

Authors:  Christian Morath; Martin Zeier; Bernd Döhler; Jan Schmidt; Peter P Nawroth; Gerhard Opelz
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.